Course:
Recreational drugs and sedation
Continuing Education Credits:
0 CE
Course Presenter(s):
Anthony FeckEducation Methods:
Category:
Date Added:
12/16/2024
Course Overview
In November 2020, Oregon legalized the use of psilocybin (magic mushrooms) and micro-dosing of LSD. Marijuana use is legal in 25 states and counting. With the rapid increase of state laws allowing certain recreational drug use as well as the ongoing use of illegal substances, the dental team providing safe and effective sedation must have a working knowledge of the medications their patients are taking, with or without medical supervision. This timely and informative program will review some of the most common recreational drugs – from alcohol to LSD – and their impact on delivering sedation dentistry. A Q&A session from the original recording follows for additional insights.
Course Objectives
1. Learn the four basic categories of recreational drugs
2. The two types of interactions between alcohol and sedation medications – and their potential consequences
3. Review the increasingly legal use of marijuana for recreational and medical use in the U.S.
4. The impact of marijuana on sedation and treatment protocols to overcome it
5. Learn the potency of fentanyl compared to morphine and heroin
6. Oral and IV sedation protocols for the patient taking fentanyl for medical reasons
7. The pharmacology of methamphetamines and why it’s highly addictive
8. The practice of micro-dosing LSD (Lysergic Acid Diethylamide)
9. Determine the pattern and time frame of LSD use prior to sedation
10. Psilocybin (mushrooms), a naturally occurring psychedelic gaining legal ground in recent years
11. The use of Ketamine in treating psychiatric disorders
Course Instructors
Anthony Feck
As a clinician, he is particularly passionate about helping high-fear dental patients receive care comfortably and safely. This passion led him to co-found the Dental Organization for Conscious Sedat...See Bio
Dental XP
Nationally Approved PACE Program Provider for FAGD/MAGD credit.
Approval does not imply acceptance by
any regulatory authority of AGD endorsement.
10/1/2023 to 9/30/2025.
Provider ID# 217597